A M Chinnaiyan
Overview
Explore the profile of A M Chinnaiyan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
4712
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ateeq B, Kunju L, Carskadon S, Pandey S, Singh G, Pradeep I, et al.
Prostate
. 2021 Mar;
81(6):357-358.
PMID: 33683724
No abstract available.
2.
Chakravarthi B, Goswami M, Pathi S, Robinson A, Cieslik M, Chandrashekar D, et al.
Oncogene
. 2016 Jun;
35(49):6330-6340.
PMID: 27270442
MicroRNA-101, a tumor suppressor microRNA (miR), is often downregulated in cancer and is known to target multiple oncogenes. Some of the genes that are negatively regulated by miR-101 expression include...
3.
Udager A, Liu T, Skala S, Magers M, McDaniel A, Spratt D, et al.
Ann Oncol
. 2016 May;
27(9):1706-12.
PMID: 27217541
Background: Despite aggressive multimodal therapy, locally advanced and/or metastatic penile squamous cell carcinoma (SqCC) is associated with significant morbidity and mortality, indicating a need for new therapeutic options. Given the...
4.
Gillessen S, Omlin A, Attard G, de Bono J, Efstathiou E, Fizazi K, et al.
Ann Oncol
. 2016 May;
30(12):e3.
PMID: 27141017
No abstract available.
5.
Gillessen S, Omlin A, Attard G, de Bono J, Efstathiou E, Fizazi K, et al.
Ann Oncol
. 2015 Jun;
26(8):1589-604.
PMID: 26041764
The first St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identified and reviewed the available evidence for the ten most important areas of controversy in advanced prostate cancer...
6.
Russo N, Wang X, Liu M, Banerjee R, Goto M, Scanlon C, et al.
Oncogene
. 2012 Nov;
32(42):5026-37.
PMID: 23160375
Despite the dismal prognosis for patients with squamous cell carcinoma of the head and neck (SCCHN), there have been no novel treatments in over 40 years. Identification of novel tumor...
7.
Banerjee R, Mani R, Russo N, Scanlon C, Tsodikov A, Jing X, et al.
Oncogene
. 2011 May;
30(42):4339-49.
PMID: 21532618
Rap1GAP is a critical tumor suppressor gene that is downregulated in multiple aggressive cancers, such as head and neck squamous cell carcinoma, melanoma and pancreatic cancer. However, the mechanistic basis...
8.
Cao Q, Yu J, Wu L, Dallol A, Li J, Chen G, et al.
Oncogene
. 2010 Jul;
29(39):5370-80.
PMID: 20622896
The neuronal repellent SLIT2 is repressed in a number of cancer types primarily through promoter hypermethylation. SLIT2, however, has not been studied in prostate cancer. Through genome-wide location analysis we...
9.
Cao Q, Dhanasekaran S, Kim J, Mani R, Tomlins S, Mehra R, et al.
Oncogene
. 2008 Sep;
27(58):7274-84.
PMID: 18806826
Enhancer of zeste homolog 2 (EZH2) is a critical component of the polycomb-repressive complex 2 (PRC2), which is involved in gene silencing and histone H3 lysine 27 methylation. EZH2 has...
10.
Schmidt F, Bittinger F, Chinnaiyan A, Rubin M
Urologe A
. 2007 Jul;
46(9):1188-9.
PMID: 17628780
No abstract available.